Reuters logo
BRIEF-Abbott Q3 adjusted EPS $0.66 from continuing operations
2017年10月18日 / 下午1点05分 / 1 个月前

BRIEF-Abbott Q3 adjusted EPS $0.66 from continuing operations

Oct 18 (Reuters) - Abbott Laboratories:

* Abbott reports third-quarter 2017 results

* Sees FY 2017 gaap earnings per share $0.97 to $0.99 from continuing operations

* Q3 adjusted earnings per share $0.66 from continuing operations

* Q3 gaap earnings per share $0.32 from continuing operations

* Q3 earnings per share view $0.65 -- Thomson Reuters I/B/E/S

* Sees Q4 adjusted earnings per share $0.72 to $0.74 from continuing operations excluding items

* Sees FY 2017 adjusted earnings per share $2.48 to $2.50 from continuing operations

* Sees Q4 2017 gaap earnings per share $0.28 to $0.30 from continuing operations

* Q3 sales $6.8 billion versus I/B/E/S view $6.72 billion

* Abbott Laboratories - ‍narrowed its full-year 2017 eps guidance range​

* Abbott Laboratories qtrly total pediatric sales $‍975​ million, up 0.8 percent on a reported basis

* Abbott Laboratories qtrly total nutrition sales $1,768 million, up 0.8 percent on a reported basis‍​

* Abbott Laboratories - qtrly total vascular sales $‍724​ million, up 17.1 percent on reported basis

* Abbott Laboratories - qtrly total diagnostics sales $1,279 million, up 5.4 percent on a reported basis ‍​

* Abbott Laboratories - ‍on Oct. 3, 2017, Abbott completed acquisition of Alere​

* FY 2017 earnings per share view $2.50 -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $0.74 -- Thomson Reuters I/B/E/S

* Abbott Laboratories - ‍expects to initiate launch of its alinity systems in U.S. In 2018​

* Abbott Laboratories - forecasts specified items for Q4 of $0.44 related to amortization, acquisition-related expenses, cost reduction initiatives

* Abbott Laboratories - ‍forecasts net specified items for full year 2017 of approximately $1.51 per share​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below